India to Serbia: Thalidomide Export Trade Route

The India to Serbia Thalidomide corridor is one of India's established pharmaceutical export routes, with 13 shipments documented worth a combined $266.4K USD. The route is dominated by SUN PHARMACEUTICAL INDUSTRIES LIMITED, which alone accounts for roughly 35% of all export value, reflecting the consolidated nature of India's thalidomide manufacturing sector.

Across 5 active suppliers, the average shipment value stands at $20.5K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 71% of all shipments, consistent with thalidomide's non-urgent bulk-order profile.

Shipment activity peaks during April–June, with an average transit time of 24 days port-to-port. The route has recorded an annual growth rate of 18.2%, placing it at rank #15 among India's top thalidomide export destinations globally.

On the import side, key buyers of Indian thalidomide in Serbia include RHEI LIFE D.O.O BEOGRAD, NA, SOPHARMA TRADING HEAD OFFICE and 2 others. RHEI LIFE D.O.O BEOGRAD is the single largest importer with 3 shipments valued at $92.9K USD.

India's thalidomide exports to Serbia are driven primarily by a handful of large-scale manufacturers. SUN PHARMACEUTICAL INDUSTRIES LIMITED with 3 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 5 active exporters signals a competitive but concentrated market — buyers in Serbia benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — SUN PHARMACEUTICAL INDUSTRIES LIMITED, ACCURE LABS PRIVATE LIMITED, KANCHAN SAGAR PHARMACEUTICALS — together account for 86% of total trade value on this route. The average shipment value of $20.5K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as thaloma cap 100mg (thalidomide capsulesusp 100 mg) (act. qty. 4960 pack x 1x10sstrip) and thalidsp 100 thalidomide caps usp 100 mg 30's pck batch: 23itd01, suggesting that buyers in Serbia tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, RHEI LIFE D.O.O BEOGRAD is the largest importer with 3 shipments worth $92.9K USD — representing 35% of all thalidomide imports from India on this route.